📌 Key Takeaways
- Topic: Spherical vs Angular Silica: Which Filler Performs Better and When?
- Keywords: silica for sunscreen
- Published: 2026-11-20 05:50:00
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Quartz Powder for Ceramics: Functions, Grades and Particle Size Selection
- Fumed Silica Manufacturer: Production Process, Key Grades and How to Choose
- CMP Slurry Silica: Colloidal vs Fumed Silica for Chemical Mechanical Polishing
- Cheng, C.-A., Deng, T., Lin, F.-C., Cai, Y. & Zink, J. I. Supramolecular nanomachines as stimuli-responsive gatekeepers on mesoporous silica nanoparticles for antibiotic and cancer drug delivery. Theranostics 9, 3341 (2019). Article CAS PubMed Central PubMed Google Scholar
- What Is the Refractive Index of Silica? Values for Fused Silica, Quartz and Amorphous Silica
- What Is Silica Sol? Composition, Acidic vs Alkaline Types and Industrial Applications
Silicon Carbide vs Silica: Differences in Hardness, Structure and Uses
What is silica (SiO₂)?
silica 99% purity The complexity and heterogeneity of the illness microenvironment brings about the problem of poor therapeutic efficiency of single therapies. 465, 466, 467, 468, 469 The current clinical research trend has steadily shifted to multimodal synergistic therapy, as we have noted above with many examples of multimodal synergistic therapy platform construction. In multimodal synergistic therapy, the interaction between different treatment modalities can substantially boost the shortcomings of single therapy, such as overcoming the lack of light penetration depth in PDT, lowering the toxic side effects of chemotherapy, etc., and producing stronger therapeutic outcome through superimposed impacts (namely "1 + 1 > 2"). 470, 471, 472 A prominent feature of multimodal synergistic therapies is the skill to effectively overcome multidrug resistance in diseases, and MSNs are uniquely advantageous in integrating these aforementioned treatment modalities. 369, 473, 474, 475 As an illustration, most of the multidrug resistance generated during chemotherapy of malignant tumors might stem from the overexpression of transmembrane ATP-binding cassette transporter and transmembrane Ca 2+ channels. 476, 477 To address this problem, researchers used mesoporous silica nanocapsules to encapsulate and deliver the cytotoxic drug DOX and T-type Ca 2+ channel siRNA. 478 On the one hand, MSNs can bypass the drug efflux pumps and enter cells directly through endocytosis, increasing the intracellular accumulation of drugs. On the other hand, siRNA can knock down the T-type Ca 2+ channel, leading to a decrease in cytosol Ca 2+ concentration in the cytosol, thus increasing the sensitivity of tumor cells to DOX. Accordingly, the as-designed MSNs-based therapeutic system attained effective chemotherapy-gene therapy to overcome the multidrug resistance in breast cancer. 478 Besides, drug-resistant bacterial infections are a current thorny public health issue. 479 In this regard, researchers have developed a photodynamic combined lysozyme antimicrobial therapy based on upconversion NPs/MSNs nanocomposites to combat the problem of drug-resistant bacterial infections in deep tissues. Briefly, upconversion NPs were sequentially encapsulated with hierarchical coating of dense silica and dendritic mesoporous silica, followed by loading photosensitizers and lysozyme, and finally modified with bacterial hyaluronidase-response valves on the MSNs surface to accomplish controllable release of lysozyme. The results demonstrated that this system promoted direct attack of ROS on cell membranes and cytoplasm through enzymatic cell wall disassembly, resulting in an excellent bactericidal rate toward methicillin-resistant Staphylococcus aureus (> 5 log10 viability reduction). 480
What is the difference between fumed silica and precipitated silica?
silica exposure limit
What drives silica raw material prices?
fused quartz This work was supported by the National Key Research and Development Program of China (Grant No. 2021YFC2102900), the National Natural Science Foundation of China (Grant Nos. U21A2085, 82072406 and 22061130205), the Elementary Research Funds for the Central Universities and Research Projects on Biomedical Transformation of China-Japan Friendship Hospital (No. XK2022-08), the Open Foundation of State Key Laboratory of Organic-Inorganic Composites, Beijing University of Chemical Technology (No. OIC-202201010), the China National Postdoctoral Program for Innovative Talents (No. BX20220028), the China Postdoctoral Science Foundation (2022M720015), the Beijing Municipal Health Commission (BJRITO-RDP-2023) and Beijing Jishuitan Hospital Elite Young Scholar Programme (XKGG2021).
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.